$ 261.44+4.96 (+1.93%)
OpenPrice at market open
—LowLowest price today
—52-Week HighHighest past 52 weeks
—HighHighest price today
—52-Week LowLowest past 52 weeks
—Market Cap.Total company value
618.09BToday’s VolumeShares traded today
6.05MAvg. VolumeAverage shares traded
7.5MP/E RatioPrice to earnings ratio
29.65Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
IPO Date
1962-01-02Headquarters
New Brunswick, USCEO
Joaquin DuatoSector
HealthcareIndustry
Drug Manufacturers - GeneralFinancial Statements
Earnings
News

Pfizer's Yield Is Three Times Bigger. Johnson & Johnson's Dividend Has Something Pfizer Does Not
2 days agoJNJ247wallst.com

Johnson & Johnson Has Dividend Royalty Status. Does That Make It a Buy?
3 days agoJNJ247wallst.com

The Crash-Proof Portfolio: 5 Elite Dividend Stocks Built to Survive a Market Meltdown
3 days agoJNJ247wallst.com

Johnson & Johnson (NYSE:JNJ) vs. Fortress Biotech (NASDAQ:FBIO) Head to Head Review
3 days agoJNJdefenseworld.net

Rep. Lloyd Doggett Purchases Shares of Johnson & Johnson (NYSE:JNJ)
3 days agoJNJdefenseworld.net

Home Depot (NYSE:HD) Stock Purchase Disclosed by Rep. Lloyd Doggett
3 days agoJNJdefenseworld.net
News
Related Companies
ABBVAbbVie Inc.
276.47
AMGNAmgen Inc.
414.87
AZNAstraZeneca PLC
159.20
BMYBristol-Myers Squibb Company
59.12














